Osasenaga Macdonald Ighodaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Osasenaga Macdonald Ighodaro has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
A.M. Adeosun
3 shared publicationsF.O. Asejeje
3 shared publicationsOluseyi Adeboye Akinloye
Department of Biochemistry, Faculty of Sciences, Lead City University, Ibadan, Nigeria
2 shared publicationsT.S. Ujomu
2 shared publicationsA. M. Adeosun
Department of Biochemistry, Lead City University, Ibadan, Nigeria
1 shared publication- Abiola M. Adeosun
Department of Biochemistry, Lead City University, Ibadan, Nigeria
1 shared publication
Latest Publications
- Open Access
- 19 August 2025
- Published by MDPI AG in Preprints.org
Targeting Molecular Markers of Neurodegeneration for Early Therapeutic Intervention in the Pathophysiology and Progression of Diabetic Retinopathy
Retinal neuronal dysfunction and degeneration emerge early in the pathogenesis of diabetic retinopathy (DR), preceding visible microvascular abnormalities. These neuronal alterations driven by chronic hyperglycemia initiate a cascade of mitochondrial failure, neuroinflammation, and synaptic disruption, which ultimately contribute to vascular breakdown and vision loss. A growing body of evidence identifies specific biomarkers that reflect these early neurodegenerative processes. Structural changes such as ganglion cell complex thinning and disorganization of the retinal inner layers (DRIL), functional impairments in flicker-induced vasodilation and oscillatory potentials, and molecular signals including caspase-3, Glial Fibrillary Acidic Protein (GFAP), and neurofilament light chain are quantifiable indicators of retinal neuronal injury. Emerging candidates such as miRNAs, retinal extracellular vesicle content, and semaphorin 3A provide additional insights into axonal transport defects and protein misfolding. Advances in artificial intelligence particularly in Optical Coherence Tomography (OCT), Optical Coherence Tomography Angiography (OCTA) image analysis, and pupillometry analysis have shown promise in enhancing the sensitivity and precision of early biomarker detection, enabling more objective risk prediction and monitoring. This review synthesizes current findings on neurodegeneration-related biomarkers in DR, emphasizing their potential for early diagnosis, risk stratification, and therapeutic monitoring. Broader clinical application will require non-invasive detection platforms, standardized protocols, and biomarker-driven trials aimed at shifting DR management toward proactive neuroprotection.
- 19 August 2025
- Published by MDPI AG in Preprints.org
Open AccessTargeting Molecular Markers of Neurodegeneration for Early Therapeutic Intervention in the Pathophysiology and Progression of Diabetic Retinopathy
Retinal neuronal dysfunction and degeneration emerge early in the pathogenesis of diabetic retinopathy (DR), preceding visible microvascular abnormalities. These neuronal alterations driven by chronic hyperglycemia initiate a cascade of mitochondrial failure, neuroinflammation, and synaptic disruption, which ultimately contribute to vascular breakdown and vision loss. A growing body of evidence identifies specific biomarkers that reflect these early neurodegenerative processes. Structural changes such as ganglion cell complex thinning and disorganization of the retinal inner layers (DRIL), functional impairments in flicker-induced vasodilation and oscillatory potentials, and molecular signals including caspase-3, Glial Fibrillary Acidic Protein (GFAP), and neurofilament light chain are quantifiable indicators of retinal neuronal injury. Emerging candidates such as miRNAs, retinal extracellular vesicle content, and semaphorin 3A provide additional insights into axonal transport defects and protein misfolding. Advances in artificial intelligence particularly in Optical Coherence Tomography (OCT), Optical Coherence Tomography Angiography (OCTA) image analysis, and pupillometry analysis have shown promise in enhancing the sensitivity and precision of early biomarker detection, enabling more objective risk prediction and monitoring. This review synthesizes current findings on neurodegeneration-related biomarkers in DR, emphasizing their potential for early diagnosis, risk stratification, and therapeutic monitoring. Broader clinical application will require non-invasive detection platforms, standardized protocols, and biomarker-driven trials aimed at shifting DR management toward proactive neuroprotection.
- Open Access
- 8 November 2021
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 7 (1) , 1-7
Combination therapy of Allium cepa L. and Cucumis sativa L. extracts in streptozotocin-induced diabetic rat model
- 8 November 2021
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 7 (1) , 1-7
Open AccessCombination therapy of Allium cepa L. and Cucumis sativa L. extracts in streptozotocin-induced diabetic rat model
- Open Access
- 1 December 2020
- Published by Elsevier in Metabolism Open
- Vol. 8
Erythropoietic potential of Parquetina nigrescens in cephalosporin-induced anaemia model
- 1 December 2020
- Published by Elsevier in Metabolism Open
- Vol. 8
Open AccessErythropoietic potential of Parquetina nigrescens in cephalosporin-induced anaemia model
- Open Access
- 1 December 2020
- Published by Elsevier in Metabolism Open
- Vol. 8
Protective role of apple cider vinegar (APCV) in CCl4-induced renal damage in wistar rats
- 1 December 2020
- Published by Elsevier in Metabolism Open
- Vol. 8
Open AccessProtective role of apple cider vinegar (APCV) in CCl4-induced renal damage in wistar rats
- Open Access
- 1 January 2020
- Published by Elsevier in Toxicology Reports
- Vol. 7, 1393-1401
Toxicity and gas chromatography-mass spectrometry analyses of a polyherbal formulation commonly used in Ibadan metropolis, Nigeria
- 1 January 2020
- Published by Elsevier in Toxicology Reports
- Vol. 7, 1393-1401
Open AccessToxicity and gas chromatography-mass spectrometry analyses of a polyherbal formulation commonly used in Ibadan metropolis, Nigeria
- Top Cited PapersOpen Access
- 1 December 2018
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 108, 656-662
Molecular pathways associated with oxidative stress in diabetes mellitus
- 1 December 2018
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 108, 656-662
Top Cited PapersOpen AccessMolecular pathways associated with oxidative stress in diabetes mellitus
- Open Access
- 23 February 2018
- Published by Juniper Publishers in Journal of Complementary Medicine & Alternative Healthcare
- Vol. 5 (4)
Anti-Peptic Ulcer Potential of a Polyherbal Mixture in Indomethacin-Induced Rat Model
- 23 February 2018
- Published by Juniper Publishers in Journal of Complementary Medicine & Alternative Healthcare
- Vol. 5 (4)
Open AccessAnti-Peptic Ulcer Potential of a Polyherbal Mixture in Indomethacin-Induced Rat Model
- Open Access
- 8 December 2017
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 525
Anti-diabetic potential of Sapium ellipticum (Hochst) Pax leaf extract in Streptozotocin(STZ)-induced diabetic Wistar rats
Ethnobatanical survey associates Sapium ellipticum (SE) with antidiabetic usage among other medicinal functions in different parts of Africa. More importantly, previous studies on the plant extract in our laboratory showed that SE has significant effects on the activities of carbohydrate metabolizing enzymes such as glucokinase, glucose-6-phosphatase, α-amylase and α-glucosidase. In view of these, the anti-diabetic potential of the plant leaf extract in streptozotocin (STZ)-induced diabetes rat model (Wistar strain) was examined. Diabetes was induced in experimental animals via single intraperitoneal dose (55 mg/kg BW) of freshly prepared STZ. SE was evaluated at 400 and 800 mg kg−1 of body weight (BW), against metformin (12 mgkg−1 BW). Treatments were done orally (p.o), twice daily at 8 h interval for a period of 21 days. SE significantly reduced fasting blood glucose (FBG) level by 46.5 and 44.4% (400 and 800 mg dosage respectively) compared to initial diabetic values. However, the effects were significantly lower than 72.6% glucose reduction produced by metformin. Hepatic and skeletal muscle glycogens were observed to increase by 27.06 and 12.55% respectively in SE-treated rats (800 mg dosage) compared to their corresponding values in diabetic control animals. Plasma and pancreatic insulin contents were also improved (31.77 and 52.34% respectively) by SE administration. The histopathological examination of the pancreas indicates beta cells regeneration in the treated animals, particularly in diabetic rats treated with 800 mg dosage of the extract compared to the diabetic control animals and metformin group. The presence of phenolic compounds namely amentoflavone, lupeol and luteolin-7-O-glucoside in SE as characterized and reported in our previous study is likely responsibly for the antidiabetic effects of the plant extract noted in the present study. The outcome of this study provides scientific basis in support of the medicinal relevance of SE and lend credence to its utilization in folk medicine for the treatment of diabetes and other oxidative stress-related ailments.
- 8 December 2017
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 525
Open AccessAnti-diabetic potential of Sapium ellipticum (Hochst) Pax leaf extract in Streptozotocin(STZ)-induced diabetic Wistar rats
Ethnobatanical survey associates Sapium ellipticum (SE) with antidiabetic usage among other medicinal functions in different parts of Africa. More importantly, previous studies on the plant extract in our laboratory showed that SE has significant effects on the activities of carbohydrate metabolizing enzymes such as glucokinase, glucose-6-phosphatase, α-amylase and α-glucosidase. In view of these, the anti-diabetic potential of the plant leaf extract in streptozotocin (STZ)-induced diabetes rat model (Wistar strain) was examined. Diabetes was induced in experimental animals via single intraperitoneal dose (55 mg/kg BW) of freshly prepared STZ. SE was evaluated at 400 and 800 mg kg−1 of body weight (BW), against metformin (12 mgkg−1 BW). Treatments were done orally (p.o), twice daily at 8 h interval for a period of 21 days. SE significantly reduced fasting blood glucose (FBG) level by 46.5 and 44.4% (400 and 800 mg dosage respectively) compared to initial diabetic values. However, the effects were significantly lower than 72.6% glucose reduction produced by metformin. Hepatic and skeletal muscle glycogens were observed to increase by 27.06 and 12.55% respectively in SE-treated rats (800 mg dosage) compared to their corresponding values in diabetic control animals. Plasma and pancreatic insulin contents were also improved (31.77 and 52.34% respectively) by SE administration. The histopathological examination of the pancreas indicates beta cells regeneration in the treated animals, particularly in diabetic rats treated with 800 mg dosage of the extract compared to the diabetic control animals and metformin group. The presence of phenolic compounds namely amentoflavone, lupeol and luteolin-7-O-glucoside in SE as characterized and reported in our previous study is likely responsibly for the antidiabetic effects of the plant extract noted in the present study. The outcome of this study provides scientific basis in support of the medicinal relevance of SE and lend credence to its utilization in folk medicine for the treatment of diabetes and other oxidative stress-related ailments.
- Open Access
- 7 August 2017
- Published by Wiley in International Scholarly Research Notices
- Vol. 2017, 1-3
Fortification of Ogi with Whey Increases Essential Amino Acids Content of Fortified Product
The inability of humans to synthesize essential amino acids (EAA) necessitates the need to increase the levels of these nutrient molecules in certain foods in which they are deficient. Maize ogi is a typical food product for both infants and adults in Africa, but with poor EAA content. This study therefore sought to assess the possibility of increasing the EAA content in maize ogi by processing it with cheese whey instead of water. Maize ogi and whey-fortified ogi were prepared by the usual procedure of grain soaking, milling, and drying. Samples from both treatments were subjected to proximate composition and amino acid profile analyses using Waters 616/626 LC (HPLC) instrument. L-lysine, L-trytophan, and L-methionine contents in maize ogi remarkably increased from 0.52, 0.15, and 0.90 mg/100 gm sample, respectively, to 0.90, 240, and 1.320 mg/100 gm sample in whey-fortified ogi. There were also significant increases in other EAA contents of whey-fortified ogi relative to its counterpart (normal maize ogi). The sum increase in EAA contents (9,405 mg) correlates with the increase in protein (1 gm) per gram sample. This study demonstrates that cheese whey increases EAA content in maize ogi and suggests that whey-fortified maize ogi may be a preferred alternative to water processed maize ogi.
- 7 August 2017
- Published by Wiley in International Scholarly Research Notices
- Vol. 2017, 1-3
Open AccessFortification of Ogi with Whey Increases Essential Amino Acids Content of Fortified Product
The inability of humans to synthesize essential amino acids (EAA) necessitates the need to increase the levels of these nutrient molecules in certain foods in which they are deficient. Maize ogi is a typical food product for both infants and adults in Africa, but with poor EAA content. This study therefore sought to assess the possibility of increasing the EAA content in maize ogi by processing it with cheese whey instead of water. Maize ogi and whey-fortified ogi were prepared by the usual procedure of grain soaking, milling, and drying. Samples from both treatments were subjected to proximate composition and amino acid profile analyses using Waters 616/626 LC (HPLC) instrument. L-lysine, L-trytophan, and L-methionine contents in maize ogi remarkably increased from 0.52, 0.15, and 0.90 mg/100 gm sample, respectively, to 0.90, 240, and 1.320 mg/100 gm sample in whey-fortified ogi. There were also significant increases in other EAA contents of whey-fortified ogi relative to its counterpart (normal maize ogi). The sum increase in EAA contents (9,405 mg) correlates with the increase in protein (1 gm) per gram sample. This study demonstrates that cheese whey increases EAA content in maize ogi and suggests that whey-fortified maize ogi may be a preferred alternative to water processed maize ogi.
- Open Access
- 7 June 2017
- Published by Wiley in International Scholarly Research Notices
- Vol. 2017, 1-5
Sapium ellipticum(Hochst.) Pax Ethanol Leaf Extract Maintains Lipid Homeostasis in Streptozotocin-Induced Diabetic Rats
Dyslipidemia is a common metabolic disorder especially in diabetes mellitus (DM). In this study, the ability ofSapium ellipticum(SE) leaf extract to restore lipid homeostasis in streptozotocin-induced diabetes was examined. DM was induced in experimental rats (Wistar strains) using single intraperitoneal dose (55 mg/kg body weight) of streptozotocin (STZ). Treatment of diabetic rats with SE was oral (p.o), at doses of 400 and 800 mg kg−1BW, twice daily at 8 h interval for 21 days. Lipid parameters were analyzed in the serum of rats using test kits. SE caused a significant () reduction in STZ-induced hypercholesterolemia in a dose dependent pattern (13.7 and 17.89%). These effects were comparable to that provided by metformin (15.45%), a standard antidiabetic drug. Similar pattern was noted with serum triglycerides (TG) (10.63 and 19.06%) and LDL (31.47 and 25.97%). Adipose tissue TG level was improved to near normal. Besides, the cardiovascular risk predictors in terms of atherogenic index of plasma (AIP) and LDL/HDL ratio were lowered by 57.85 and 44.12%, respectively. However, the extract failed to significantly reverse the STZ-induced decline in serum HDL. Overall, with AIP value of 0.28 and LDL/HDL ratio of 0.91, SE demonstrated the potential to maintain lipid homeostasis in the diabetics.- 7 June 2017
- Published by Wiley in International Scholarly Research Notices
- Vol. 2017, 1-5
Open AccessSapium ellipticum(Hochst.) Pax Ethanol Leaf Extract Maintains Lipid Homeostasis in Streptozotocin-Induced Diabetic Rats
Dyslipidemia is a common metabolic disorder especially in diabetes mellitus (DM). In this study, the ability ofSapium ellipticum(SE) leaf extract to restore lipid homeostasis in streptozotocin-induced diabetes was examined. DM was induced in experimental rats (Wistar strains) using single intraperitoneal dose (55 mg/kg body weight) of streptozotocin (STZ). Treatment of diabetic rats with SE was oral (p.o), at doses of 400 and 800 mg kg−1BW, twice daily at 8 h interval for 21 days. Lipid parameters were analyzed in the serum of rats using test kits. SE caused a significant () reduction in STZ-induced hypercholesterolemia in a dose dependent pattern (13.7 and 17.89%). These effects were comparable to that provided by metformin (15.45%), a standard antidiabetic drug. Similar pattern was noted with serum triglycerides (TG) (10.63 and 19.06%) and LDL (31.47 and 25.97%). Adipose tissue TG level was improved to near normal. Besides, the cardiovascular risk predictors in terms of atherogenic index of plasma (AIP) and LDL/HDL ratio were lowered by 57.85 and 44.12%, respectively. However, the extract failed to significantly reverse the STZ-induced decline in serum HDL. Overall, with AIP value of 0.28 and LDL/HDL ratio of 0.91, SE demonstrated the potential to maintain lipid homeostasis in the diabetics.